Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Hydrocarbon doai
Patent
1995-06-07
1999-03-16
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Hydrocarbon doai
514725, 514717, 514731, A61K 31015, A61K 3107
Patent
active
058831363
ABSTRACT:
This invention provides methods of inhibiting the growth of cells, of treating a subject having a disease characterized by an uncontrolled growth of cells and of blocking an immune response as well as related inflammatory responses in a subject which comprises administering a compound having the structure: ##STR1##
REFERENCES:
Buck, et al., Retinol Is Essential For Growth Of Activated Human B Cells, J. Exp. Med. 171: 1613-1624 (1990).
Buck, et al., Differences in the Action and Metabolism Between Retinol and Retinoic Acid in B Lymphocytes, J. Cell Biology 115(3): 851-859 (1991).
Garbe, A., et al., Retinoids Are Important Cofactors in T Cell Activation, J. Exp. Med. 176: 109-117 (1992).
Jochen, Buck, et al., Intracellular Signaling by 14-Hydroxy-4, 14-Retro-Retinol, Science 254: 1654-1656 (1991).
Wald, George, Molecular Basis of Visual Excitation, Science 162: 230-239 (1968).
Roberts, et al., in The Retinoids, vol. 2 (eds. M.B. Sporn, A.B. Roberts, and D.S. Goodman) pp. 209-286 (1984).
Evans, Ronald M., The Steroid and Thyroid Hormone Receptor Superfamily, Science 240: 889-895 (1988).
Green, S. and Chambon, P., Nuclear Receptors Enhance Our Understanding of Transcription Regulation, Trends in Genet., 4: 309-314 (1988).
Leo, et al., Identification of a Monoclonal Antibody Specific for a Murine T3 Polypeptide, Proc. Natl. Acad. Sci USA 84: 1374-1378 (1987).
Gillis, et al., Long Term Culture of Tumour-Specific Cytotoxic T Cells, Nature 268: 154-156 (1977).
Cogan, et al., Binding Affinities of Retinol and Related Compounds to Retinol Binding Proteins, Eur. J. Biochem. 65: 71-78 (1976).
McClean, et al., Liquid Chromatographic Assay for Retinol (Vitamin A) and Retinol Analogs in Therapeutic Trials, Clin. Chem. 28: 693-696 (1982).
Schreckenbach, et al., Properties of the Retinal Binding Site in Bacteriorhodopsin: Use of Retinol and Retinyl Moieties as Fluorescent Probes, Photochem. Photobio. 28: 205-211 (1978).
Mallia, et al., Preparation, Properties and Metabolism of retro-3-Dehydroretinyl Acetate, Biochem. J. 109: 293-299 (1968).
Favennec, et al., The Biological Effects of Retinoids on Cell Differentiation and Proliferation, J. Clin. Chem. Clin. Biochem., 26: 479-489 (1988).
Shealy, Y., Synthesis and Evaluation of Some New Retinoids For Cancer Chemoprevention, Preventive Medicine 18: 624-645 (1989).
Muto, Y., et al., Antitumor Activity of Vitamin A and its Derivatives, Chemical Abstracts 102: 125184u (1984).
Buck Jochen
Derguini Fadila
Hammerling Ulrich
Nakanishi Koji
MacMillan Keith D.
Sloan-Kettering Institute for Cancer Research
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Anhydroretinol and derivatives thereof as antagonists of immune does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anhydroretinol and derivatives thereof as antagonists of immune , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anhydroretinol and derivatives thereof as antagonists of immune will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-818164